Corneal Endothelial Dystrophy
8 clinical trials · Condition
◉ Watch Corneal Endothelial Dystrophy
| Record | Firm | Date |
|---|---|---|
| A Safety and Efficacy Trial of TTHX1114 in People With CED (NCT04812067) | Trefoil Therapeutics, Inc. | 2021-11-30 |
| Loteprednol Etabonate 0.25% for Prevention of Cornea Transplant Rejection (NCT05136443) | Price Vision Group | 2021-11-23 |
| Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema (NCT04894110) | Emmecell | 2021-06-22 |
| A Phase 1/ Phase 2 Study of TTHX1114(NM141) (NCT04520321) | Trefoil Therapeutics, Inc. | 2020-08-19 |
| Ripasudil 0.4% Eye Drops in Fuchs Endothelial Corneal Dystrophy (NCT03575130) | University of Erlangen-Nürnberg Medical School | 2018-06-05 |
| Phase 1 Study to Evaluate the Safety and Tolerability of EO1404 in the Treatment of Corneal Edema (NCT04191629) | Valeria Sanchez-Huerta | 2016-05-04 |
Track Corneal Endothelial Dystrophy automatically
Every clearance here is in the API, with alerts when new ones post.